Author
Ahsanullah Niazai
Recent research
- Health & MedicineOpen access
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve heart failure outcomes, but their association with arrhythmic events and device-therapy endpoints in patients with implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator...